Alejandro Cané

1.2k total citations
56 papers, 688 citations indexed

About

Alejandro Cané is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Alejandro Cané has authored 56 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 14 papers in Infectious Diseases and 13 papers in Microbiology. Recurrent topics in Alejandro Cané's work include Pneumonia and Respiratory Infections (32 papers), Respiratory viral infections research (28 papers) and Bacterial Infections and Vaccines (12 papers). Alejandro Cané is often cited by papers focused on Pneumonia and Respiratory Infections (32 papers), Respiratory viral infections research (28 papers) and Bacterial Infections and Vaccines (12 papers). Alejandro Cané collaborates with scholars based in United States, United Kingdom and Argentina. Alejandro Cané's co-authors include Daniel Curcio, F. FERNÁNDEZ, Mary M. Moran, Raúl Istúriz, Verna Welch, Manuela Di Fusco, Ashley Enstone, Jennifer L. Nguyen, Bradford D. Gessner and Amit Srivastava and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Alejandro Cané

45 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Cané United States 17 427 213 121 118 64 56 688
Alane Izu South Africa 19 538 1.3× 241 1.1× 80 0.7× 61 0.5× 57 0.9× 64 887
Catherine Eppes United States 16 205 0.5× 170 0.8× 87 0.7× 75 0.6× 102 1.6× 43 887
Luz María Vilca Spain 14 214 0.5× 164 0.8× 161 1.3× 56 0.5× 51 0.8× 24 592
J. Kevin Yin Australia 17 506 1.2× 197 0.9× 149 1.2× 63 0.5× 23 0.4× 35 697
Parveen Fathima Australia 15 438 1.0× 160 0.8× 116 1.0× 45 0.4× 75 1.2× 48 592
Vincent Ciuryla United States 11 640 1.5× 119 0.6× 99 0.8× 135 1.1× 47 0.7× 18 824
Lisa McHugh Australia 15 288 0.7× 79 0.4× 110 0.9× 66 0.6× 43 0.7× 38 589
David Moreno‐Pérez Spain 14 557 1.3× 226 1.1× 99 0.8× 181 1.5× 77 1.2× 84 773
J. Gaillat France 15 568 1.3× 170 0.8× 166 1.4× 50 0.4× 43 0.7× 49 837
Jessica E. Atwell United States 14 508 1.2× 263 1.2× 252 2.1× 87 0.7× 34 0.5× 30 770

Countries citing papers authored by Alejandro Cané

Since Specialization
Citations

This map shows the geographic impact of Alejandro Cané's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Cané with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Cané more than expected).

Fields of papers citing papers by Alejandro Cané

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Cané. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Cané. The network helps show where Alejandro Cané may publish in the future.

Co-authorship network of co-authors of Alejandro Cané

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Cané. A scholar is included among the top collaborators of Alejandro Cané based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Cané. Alejandro Cané is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arrieta, Antonio, Lindsay R. Grant, Bradford D. Gessner, et al.. (2025). Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis. The Pediatric Infectious Disease Journal. 44(7). 622–629.
3.
Fergie, Jaime, Gary S. Marshall, Jana Shaw, et al.. (2025). Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination. Infectious Diseases and Therapy. 14(7). 1381–1403.
4.
Weycker, Derek, Rotem Lapidot, Mark H. Rozenbaum, et al.. (2025). Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US children. Journal of Medical Economics. 28(1). 517–523.
5.
Andersen, Kathleen M., et al.. (2025). Clinical Outcomes in Children <5 Years of Age Hospitalized for Respiratory Syncytial Virus, COVID-19 or Influenza in the United States. The Pediatric Infectious Disease Journal. 44(11). 1018–1024.
6.
7.
Cané, Alejandro, et al.. (2024). The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US. Vaccines. 12(11). 1279–1279. 1 indexed citations
8.
Rozenbaum, Mark H., Liping Huang, Alejandro Cané, et al.. (2024). Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13. Journal of Medical Economics. 27(1). 644–652. 6 indexed citations
9.
Ramírez, Julio A., Robin Hubler, Mohammad Ali, et al.. (2024). Streptococcus pneumoniae Serotype Distribution Among US Adults Hospitalized With Community-Acquired Pneumonia, 2019–2020. Open Forum Infectious Diseases. 12(1). ofae727–ofae727. 1 indexed citations
10.
Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2024). Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Vaccine. 42(3). 573–582. 10 indexed citations
11.
Langer, J, Verna Welch, Mary M. Moran, et al.. (2024). The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults. Advances in Therapy. 41(3). 945–966. 12 indexed citations
12.
Lewnard, Joseph A., Vennis Hong, Katia Bruxvoort, et al.. (2023). Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United States. Clinical Infectious Diseases. 77(9). 1340–1352. 7 indexed citations
13.
Snow, Vincenza, Alejandro Cané, Paula Peyrani, et al.. (2023). 1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
14.
Welch, Verna, Mary M. Moran, Alejandro Cané, et al.. (2023). High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review. Advances in Therapy. 40(4). 1601–1627. 49 indexed citations
15.
Vietri, Jeffrey, Liping Huang, Vincenza Snow, et al.. (2023). 1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
16.
17.
McGrath, Leah J., Mary M. Moran, Tamuno Alfred, et al.. (2023). Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US. Frontiers in Pediatrics. 11. 1261046–1261046. 4 indexed citations
18.
Lewnard, Joseph A., Katia Bruxvoort, Heidi Fischer, et al.. (2021). Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults. Clinical Infectious Diseases. 75(5). 832–841. 31 indexed citations
19.
Curcio, Daniel, et al.. (2019). Surgical site infection in elective clean and clean-contaminated surgeries in developing countries. International Journal of Infectious Diseases. 80. 34–45. 53 indexed citations
20.
Giglio, Norberto, et al.. (2010). Costo-efectividad de la vacunación universal antineumocócica en Uruguay. Revista Panamericana de Salud Pública. 28(2). 92–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alane Izu Breakdown of academic impact, for papers by Catherine Eppes Breakdown of academic impact, for papers by Luz María Vilca Breakdown of academic impact, for papers by J. Kevin Yin Breakdown of academic impact, for papers by Parveen Fathima Breakdown of academic impact, for papers by Vincent Ciuryla Breakdown of academic impact, for papers by Lisa McHugh Breakdown of academic impact, for papers by David Moreno‐Pérez Breakdown of academic impact, for papers by J. Gaillat Breakdown of academic impact, for papers by Jessica E. Atwell
Rankless by CCL
2026